- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case C-427/09: Judgment of the Court (Second Chamber) of 28 July 2011 (reference for a preliminary ruling from the Court of Appeal (England and Wales) (Civil Division) (United Kingdom)) — Generics (UK) Ltd v Synaptech Inc (Patent law — Medicinal products — Supplementary protection certificate for medicinal products — Regulation (EEC) No 1768/92 — Article 2 — Scope)
ECLI:EU:UNKNOWN:62009CA0427
62009CA0427
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C 298/3
(Case C-427/09)(1)
(Patent law - Medicinal products - Supplementary protection certificate for medicinal products - Regulation (EEC) No 1768/92 - Article 2 - Scope)
2011/C 298/04
Language of the case: English
Referring court
Parties to the main proceedings
Applicant: Generics (UK) Ltd
Defendant: Synaptech Inc
Re:
Reference for a preliminary ruling — Court of Appeal (England and Wales) (Civil Division) — Interpretation of Article 13(1) of Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products (OJ 1992 L 182, p. 1) — Concept of first authorisation to place the product on the market — Account taken only of authorisations issued in accordance with Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products (OJ, English Special Edition 1965-1966, p. 24) — Authorisation delivered in accordance with the legislation applicable in Austria before the latter acceded to the EEA.
Operative part of the judgment
A product, such as that at issue in the main proceedings, which was placed on the market in the European Community as a medicinal product for human use before obtaining a marketing authorisation in accordance with Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products, as amended by Council Directive 89/341/EEC of 3 May 1989, and, in particular, without undergoing safety and efficacy testing, is not within the scope of Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products, as amended by the Act concerning the conditions of accession of the Republic of Austria, the Republic of Finland and the Kingdom of Sweden and the adjustments to the Treaties on which the European Union is founded, as that scope is defined in Article 2 of that regulation, as amended, and may not be the subject of a supplementary protection certificate.
*
Language of the case: English.
(1)
OJ C 11, 16.1.2010.